Contents & References of Synthesis of derivatives of 2-3-indolyl)(phenylmethyl)indandiones
List:
Abstract 1
Chapter One: Introduction and Theory
1-1- Application and importance of Indan Dion. 3
1-2- Multicomponent reactions. 5
1-3- Preparation and synthesis of indonediones and its derivatives. 6
1-3-1- Natural preparation. 6
1-3-2- laboratory synthesis methods. 7
1-3-2-1-preparation of 3,1-indanediones through decarboxylation of 2-ethoxycarbonyl sodium salt. 7
1-3-2-2-Synthesis of 1,3-indandione derivatives. 7
1-3-2-3- Synthesis of stable silver organophosphine/phosphite complexes with 2-acetyl-1,3-indandione ligand with crystal structure [Ph3P.AgC11H7O3] 8
1-3-2-4- Four-component synthesis of 1,3-indanedionylamidinium betaine based on isocyanide. 8
1-3-2-5- Catalyst-free synthesis of indanediones 9
1-3-2-6- Asymmetric synthesis of polycyclic spiro 1,3-indanediones using Michael/Michael corcumenes with 2-arylidene-1,3-indanediones 9
1-3-2-7- Electrochemical synthesis of derivatives 1,3- Indan Dion. 10
1-4- Common reactions in the Novnagel condensation. 10
1-4-1- Hanesh synthesis. 10
1-4-2- digestive synthesis. 11
1-4-3- Synthesis of Fried Lander 12
1-4-4- Synthesis of Pacman. 12
1-4-5- Condensation of Novonagel isatins with malononitrile in water. 13- 1-4-6- Using hydroxyapatite as a new solid substrate for Novonagel reaction in a solvent-free heterogeneous environment 14- 1-4-7- Using isopropyl alcohol as a solvent in Novonagel reactions with Ti(O-i-Pr)4 14- 1-4-8- Electrosynthesis of 2-amino-H4-chromones 15
1-4-9-Synthesis of 2-amino-4-aryl-5-oxo-H4,H5 pyrano[2,3-C]chromone-3-carbonitrile. 15
Chapter Two: Discussion and Conclusion
2-1- The purpose of the research. 17
2-2- Preparation of 2-((4-chloro-phenyl)-(H1-indol-3-yl)-methyl)-indan-3,1-dione (a66) 18
2-3- The proposed reaction mechanism is suggested as follows: 23
2-4- Conclusion. 26
2-5- Suggestions for future work. 27
Chapter Three: Experimental Works
3-1- General techniques. 29
3-2- General method of preparation of 3,1-indanediones 29
3-3- Preparation of compound 2-((4-chloro-phenyl)-(H1-indol-3-yl)-methyl)-indan-3,1-dione (a64) 30
3-4- Preparation of compound 2-((H1-indol-3-yl)- (4-nitro-phenyl)-methyl)-indan-3,1-dione (b64) 31
3-5- preparation of compound 2-((H1-indol-3-yl)-(3-nitro-phenyl)-methyl)-indan-3,1-dione (c64) 32
3-6- preparation of compound 2-((4-bromo-phenyl)-(H1- Indole-3-yl)-methyl)-indan-3,1-dione (d64) 34
3-7-preparation of compound 2-((3-hydroxy-phenyl)-(H1-indol-3-yl)-methyl)-indan-3,1-dione (e64) 35
3-8-preparation of compound 2-((H1-indol-3-yl)- (4-methylsulfonyl-phenyl)-methyl)-indan-3,1-dione (f64) 36
3-9- preparation of compound 2-((H1-indol-3-yl)-pyridin-3-yl)-methyl)-indan-3,1-dione (g64) 37
3-10- preparation of compound 2-((2-chloro-5-nitro- Phenyl) (H1-indol-3-yl)-methyl)-indan-3,1-dione (h64) 39
3-11- preparation of compound 2-(4-methoxy-benzylidene)-indan-3,1-dione (i64) 40
3-12- preparation of compound 2-(4-dimethylamino-benzylidene)-indan-3,1- Dion (j64) 41
Resources. 84
Source:
Ahmedova, A.; Burdzhiev, N.; C. R. Chemistry. 2010, 13, 1269.
Akbarzadeh, R.; Amanpour, T.; Tetrahedron 2012, 68, 3868.
Amidi, S.; Iran J. pharm. Res. 2013, 12, 91.
Bienayme, H.; Hulme, C.; Oddon, G.; Schmitt, P. Chem. Eur. J. 2000, 6, 3321.
Biginelli, P. Chem. Ber. 1891, 24, 2962.
Blumberg, H:, Dayton, H. B.; Gordon, S. M. Science, 1958, 127, 188.
Bucherer, H. T.; Fischbeck, H. T. J. Parkt. Chem. 1934, 140, 69.
Chai, Z.; Rainey, T. Y. Y. Am. Chem. Soc. 2012, 134,3615.
Correll, J. T. Patent. U. S. Aug. 1959, 18, 2, 900, 302.
Da Siha, E. N.; Res. Y. Chem. Environment. 2007, 11, 90.
Demchuk, V. D.; Ellison, N. M.; Mendeleev Commun. 2011, 21, 224.
Dsouza, D. M.; Müller, T. J. Chem. Soc. Rev. 2007, 36, 1095.
Gori E. Thrombosis and Embolism. Ijnternational conf.; Basel 1954, P. 271.
Guillena, G.; Ram?nJ.; Yus, M. Tetrahedron: Asymmetry 2007, 18, 693.
Hantzsch, Aliebigs Ann. Chem. 1882, 75, 27.
Hazleton, L. W:, Dolbery W.H. Patent. U.S.Apr. 1959, 28, 2, 884, 357.
Kubovic, M:, Prazic, M.; Atunackovic, D. Proc. Soc. ExpRiol. Med, 1955, 90, 660.
Lasri, J.; Gajewski, G.; Tetrahedron 2012, 68, 7019.
Luo, N.; Sun, X.; Tetrahedron 2013, 24, 402.
Makarem, S.; Mohammadi, A. A.; Fakhari, A. R.; Tetrahedron 2008, 49, 7194.
Mannich, C.; Krosch, W. Arch. Pharm. 1912, 250, 647.
Passerini, M.; Simone, L. Gazz. Chim. Ital. 1921, 51, 126.
Pirrung, M. C.; Sarma, K. D. Y. Am. Chem. Soc. 2004, 126, 444.
Pizzirani, D:, Roberti, M.; Grimaudo, S. Tetrahedron 2008, 93, 452
Robinson, R. J. Chem. Soc. 1917, 111, 876.
Sainsbury, M.; Heterocyclic Chemistry.; Royal Society Of Chemistry Publication. 1998, 28, 47, 63.
Septi, S.; Tahir, R.; Applied Catalysis A: General. 2002, 228, 155. Shaterian, H. R.; Arman, M.; Rigi, F.; J. Mol. Liq. 2011, 158, 145. Shaterian, H. R.; Hosseinian, A.; Ghashang, M. Turk. J. Chem. 2009, 2, 233.
Soderberg, U.; Wachmeister, C. A. Pharmacol, J. Exp. Therap. 1956, 117, 298
Trost, B. M. Angew. Chem., Int. Ed. English 1995, 34, 259.
Wang, N.; Tao, X.; Polyhedron. 2010, 29, 1687.
WWW.Medicinenet.Com
Yamashita, K.; Tanaka, T.; Tetrahedron 2005, 61, 7981.
Zhiwei, C.; Qiang, Z.; Tetrahedron 2011, 2604.